Gottfried von Keudell

4PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Jun 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

Alison J Moskowitz, Gunjan Shah, Heiko Schöder

|Apr 30, 2021
Genome-Wide Chromatin Analysis of FFPE Tissues Using a Dual-Arm Robot with Clinical Potential.

Syuzo Kaneko, Toutai Mitsuyama, Kouya Shiraishi

|Dec 12, 2018
Novel therapeutic agents for relapsed classical Hodgkin lymphoma.

Gottfried von Keudell, Anas Younes

Pageof 1

Frequent Collaborators

1 joint publications

Syuzo Kaneko

1 joint publications

Toutai Mitsuyama

1 joint publications

Kouya Shiraishi

1 joint publications

Kanto Shozu